1. Merck and Sanofi both buying smaller cancer oncology companies at big premiums — The latest from ASH2019 conference — Biopharma Dive’s drug launch of the year: Zolgensma — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Heron Therapeutics

Anonymous board for Heron Therapeutics


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    14
    Views:
    2,544
  2. anonymous
    Replies:
    12
    Views:
    3,844
  3. anonymous
    Replies:
    12
    Views:
    5,377
  4. anonymous
    Replies:
    5
    Views:
    1,165
  5. anonymous
    Replies:
    2
    Views:
    3,237
  6. anonymous
    Replies:
    19
    Views:
    3,440
  7. anonymous
    Replies:
    14
    Views:
    2,532
  8. anonymous
    Replies:
    3
    Views:
    1,040
  9. anonymous
    Replies:
    79
    Views:
    9,866
  10. anonymous
    Replies:
    4
    Views:
    1,345
  11. anonymous
    Replies:
    6
    Views:
    1,241
  12. anonymous
    Replies:
    3
    Views:
    837
  13. anonymous
    Replies:
    9
    Views:
    1,948
  14. anonymous
    Replies:
    14
    Views:
    1,457
  15. anonymous
    Replies:
    4
    Views:
    940
  16. anonymous
    Replies:
    4
    Views:
    1,087
  17. anonymous
    Replies:
    4
    Views:
    1,539
  18. anonymous
    Replies:
    4
    Views:
    2,421
  19. anonymous
    Replies:
    2
    Views:
    1,431
  20. anonymous
    Replies:
    1
    Views:
    1,466

Thread Display Options

Loading...